DESTINY SPRINGS HEALTHCARE
1. Target Overview & Investment Thesis
DESTINY SPRINGS HEALTHCARE is a 90-bed community hospital in nan, AZ with $30.4M in net patient revenue and a 25.6% operating margin. The hospital serves a payer mix of 1.8% Medicare, 0.0% Medicaid, and 98.2% commercial.
Thesis: Turnaround. Our ML models identify $2.2M in annual EBITDA improvement potential from RCM optimization across 5 levers, lifting margin from 25.6% to 33.0% (+736bps).
| Net Revenue HCRIS | $30.4M |
| Current EBITDA COMPUTED | $7.8M |
| Operating Margin COMPUTED | 25.6% |
| Occupancy HCRIS | 100.0% |
| Revenue / Bed COMPUTED | $338K |
| Net-to-Gross HCRIS | 54.5% |
| Distress Probability ML | nan% |
2. Market Context & Competitive Position
AZ has 124 Medicare-certified hospitals with a median operating margin of -0.8%. The target's margin of 25.6% places it above the state median. Among 55 size-comparable peers (45-180 beds), the median margin is -0.9%. The target performs in line with or above peers.
3. RCM Performance Analysis — Comparable Hospitals
Comps selected by bed count (45-180), prioritizing same-state peers. 55 hospitals in the comp set.
| Hospital | State | Beds | Revenue | Margin |
|---|---|---|---|---|
| DESTINY SPRINGS HEALTHCARE (Target) | AZ | 90 | $30.4M | 25.6% |
| HAVASU REGIONAL MEDICAL CENTER | AZ | 144 | $256.1M | 16.9% |
| SUMMIT HEALTHCARE | AZ | 89 | $254.1M | -2.9% |
| MOUNTAIN VISTA MEDICAL CENTER | AZ | 162 | $223.9M | -1.0% |
| BANNER UNIVERSITY MED CENTER S | AZ | 132 | $190.9M | -16.3% |
| HONORHEALTH SCOTTSDALE THOMPSO | AZ | 120 | $187.9M | -1.6% |
| VERDE VALLEY MEDICAL CENTER | AZ | 87 | $172.5M | 4.3% |
| BANNER HEART HOSPITAL | AZ | 108 | $162.2M | 17.4% |
| BANNER CASA GRANDE MEDICAL CEN | AZ | 141 | $151.2M | -6.3% |
4. Predicted Improvement Opportunities
Improvement targets set at P75 of comparable peers with 60% gap closure assumption. Coefficients calibrated to published research bands. Total EBITDA uplift: $2.2M (736bps margin improvement).
| Lever | Current | Target | EBITDA Impact | Margin | Ramp |
|---|---|---|---|---|---|
| Net Collection Rate | 93.5% | 97.0% | $639K | +210bp | 18mo |
| Cost to Collect | 4.5% | 2.5% | $608K | +200bp | 12mo |
| Denial Rate Reduction | 12.0% | 6.5% | $602K | +198bp | 12mo |
| A/R Days Reduction | 5200.0% | 3800.0% | $370K | +122bp | 9mo |
| Clean Claim Rate | 88.0% | 96.0% | $19K | +6bp | 6mo |
5. EBITDA Bridge
| Current EBITDA | $7.8M |
| + RCM Uplift | +$2.2M |
| Pro Forma EBITDA | $10.0M |
| Current Margin | 25.6% |
| Pro Forma Margin | 33.0% |
| WC Released (1x) | $1.2M |
6. Returns Analysis — Scenario Matrix
5-year hold, 5.5x leverage, 3% organic growth, 10%/yr debt paydown. Base case uses 100% of predicted RCM uplift. Bull case: 130% uplift at lower entry. Bear case: 50% uplift at higher entry.
| Scenario | Entry | Exit | Equity In | Equity Out | MOIC | IRR |
|---|---|---|---|---|---|---|
| Base Case | 10.0x | 10.0x | $12.0M | $73.8M | 6.15x | 43.8% |
| Base (11x exit) | 10.0x | 11.0x | $12.0M | $85.1M | 7.09x | 48.0% |
| Bull Case | 9.0x | 11.0x | $10.8M | $96.4M | 8.93x | 54.9% |
| Bull (12x exit) | 9.0x | 12.0x | $10.8M | $108.4M | 10.03x | 58.6% |
| Bear Case | 11.0x | 10.0x | $13.2M | $58.8M | 4.45x | 34.8% |
| Bear (11x exit) | 11.0x | 11.0x | $13.2M | $68.9M | 5.22x | 39.2% |
7. Key Risks & Mitigants
| Severity | Risk Factor | Mitigant |
|---|---|---|
| Medium | Standard execution risk | RCM improvement requires management buy-in and 12-18 month implementation timeline |
8. Data Sources & Methodology Appendix
Data Sources
- CMS HCRIS Cost Reports (Medicare-certified hospitals)
- CMS Medicare Utilization (DRG-level volumes)
- CMS Chronic Conditions (county-level disease prevalence)
- HCRIS multi-year trend data (financial time series)
Comparable Selection
- 55 hospitals with 45-180 beds
- Same-state prioritization (n=56)
- Comp margins: P25=-10.9% / P50=-0.9% / P75=6.5%
Bridge Methodology
- Targets: P75 of comparable peers (60% gap closure)
- Denial: avoidable share = 35% of delta × NPR
- AR: bad debt coefficient = $0.65 per day per $1K NPR
- NCR: 60% coefficient on collection rate improvement
- CDI: 0.75% of Medicare revenue per 0.01 CMI point
Returns Assumptions
- Leverage: 5.5x entry (84.6% debt / 15.4% equity)
- Organic growth: 3% annual EBITDA growth
- Debt paydown: 10% of principal per year
- Hold period: 5 years
Generated by SeekingChartis on April 26, 2026. All predictions use public data only. Confidence intervals calibrated via split conformal prediction (90% coverage target). This memo is for informational purposes and does not constitute investment advice.